PECS II block was found to raise the numbers of CD3+, CD4+, and CD4+/CD8+ T cells in peripheral blood 3 and 24 h after breast cancer surgery in another study,59 implying that PECS II blockade can also improve cellular immune activity in patients undergoing surgery. This evidence concerns the gene CD4 and breast cancer.